Benzamide,3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxy-, hydrochloride(1:1) (73220-03-8)

Identification
Name:	Benzamide,3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxy-, hydrochloride(1:1)
Synonyms:	Benzamide,3-bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxy-, monohydrochloride,(S)-;Benzamide,3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxy-,monohydrochloride (9CI);(-)-FLA 731;A 33547;A 33547 hydrochloride;FLA 731;FLA 731, (-)-;Remoxipride hydrochloride;Roxiam;
CAS:	73220-03-8
Molecular Formula:	C16H23 Br N2 O3 . Cl H
Molecular Weight:	407.73
InChI:	InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1
Molecular Structure:
Properties
Specification:	usageEng:Specific dopamine D2-receptor antagonist. Antipsychotic.
Biological Activity:	Standard D 2 receptor antagonist showing some selectivity over D 3 and D 4 receptors (K i values are ~ 300, ~ 1600, and ~ 2800 nM for D 2 , D 3 and D 4 receptors respectively). In vivo remoxipride is an antipsychotic which does not cause extrapyramidal side effects and is 50-fold more potent than sulpiride in antagonising the effects of apomorphine in the rat.
Storage Temperature:	Store at RT
Usage:	Specific dopamine D2-receptor antagonist. Antipsychotic.
Safety Data